Efficacy and toxicity of immune checkpoint inhibitors combination therapy for advanced renal cell carcinoma: a systematic review and network meta-analysis

Efficacy and toxicity of immune checkpoint inhibitors combination therapy for advanced renal cell carcinoma: a systematic review and network meta-analysis

BackgroundAlthough immune checkpoint inhibitors (ICIs) show a significant overall survival advantage over standard advanced renal cell carcinoma (aRCC) therapies, tumor response to these agents remains poor. Some studies have shown that combination therapy including an ICI appears to be the best tre...

Full description

Bibliographic Details
Main Authors: Xiangyu Chen, Zhunan Xu, Changgui Wu, Lijun Xie, Pengyu Wang, Xiaoqiang Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Immunology
Subjects:
immune checkpoint inhibitors
tyrosine kinase inhibitors
advanced renal cell carcinoma
combination therapy
efficacy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1255577/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1255577/full

Similar Items